What Is BAM15? Dosage, Half-Life & How to Track It

What BAM15 is and how it works

Your mitochondria make usable energy (ATP) by pumping protons across an inner membrane and then letting them flow back through a specific channel that captures the energy. A mitochondrial uncoupler short-circuits that: it lets protons leak back across the membrane through a different route, bypassing the energy-capturing step. The proton-pumping keeps happening — the cell just gets heat instead of ATP, and to compensate, it burns more fuel (fat and glucose) trying to keep up. That extra calorie burn is the entire theoretical basis for uncouplers as weight-loss agents.

The best-known uncoupler is 2,4-dinitrophenol (DNP), sold as a diet drug in the 1930s before it was pulled from the market after users died of hyperthermia — uncoupling too aggressively raises core body temperature to dangerous levels, especially under exertion or heat. BAM15 was identified in a 2014 academic screen — the original characterization work (Kenwood et al.) and the follow-up anti-obesity research trace to University of Virginia and UNSW Sydney researchers (the Hoehn lab), not Salk as sometimes reported — specifically because, in mice, it uncoupled mitochondria and protected against diet-induced obesity and insulin resistance without the same rise in core body temperature that makes DNP so dangerous — a meaningfully wider apparent safety margin, at least in that species.

It is important to be precise about what that finding does and doesn’t mean. A wider safety margin in mice is a genuinely interesting preclinical result — it is not evidence that BAM15 is safe in humans. Uncoupling mitochondria is a mechanism with real, inherent risk (hyperthermia) regardless of which specific molecule is doing it, and BAM15 has not been tested in a single published human trial to confirm the mouse finding translates.

Human dosing: there isn’t a validated one

There is no clinically established human dose for BAM15 — no Phase 1 trial has determined a safe starting dose, a maximum tolerated dose, or basic human pharmacokinetics. Some research-chemical vendors sell it as a powder or capsule, and informal doses circulate in online research-chemical and biohacking communities, but those numbers are not derived from any human study — at best they are extrapolations from mouse dosing (typically reported in mg/kg in the published animal literature), and at worst they are simply guesses.

That distinguishes BAM15 from most other early-stage compounds in this library. Peptides like BPC-157 or Follistatin-344 at least have years of informal self-use history and community-reported protocols to point to, however unvalidated. BAM15, and mitochondrial uncouplers generally, carry a documented history of causing death at the wrong dose (DNP) with no established margin of safety in humans specifically. We are deliberately not printing a "typical dose" table here, because there is no validated number to put in it.

What is (and isn’t) known about duration of action

BAM15’s half-life has not been characterized in humans. Preclinical pharmacokinetic work in mice suggests relatively fast elimination, but rodent PK data does not reliably predict a human number — species differences in metabolism are large enough that any figure quoted for "BAM15’s half-life" outside a mouse study should be treated as unverified.

In practice this means there is no dosing-frequency guidance that can honestly be given — not a "once daily," not a cycle length, nothing grounded in actual human data.

What to track & the honest risk framing

There is no established human side-effect profile for BAM15, because it hasn’t been through the trials that would generate one. Based purely on its mechanism — and the well-documented history of DNP — the theoretical warning signs of uncoupler toxicity are elevated resting heart rate, unusual warmth or sweating, and heat intolerance, particularly during exercise or in hot conditions; those are the class-level risks of mitochondrial uncoupling, not something specific to BAM15’s (unverified in humans) safety margin.

If you are choosing to track anything about BAM15, the honest framing matches Humanin and Follistatin-344 in this library, but with the volume turned up: log exactly what was taken and when, because with zero clinical reference points your own record is the only data that exists — and treat any of the classic uncoupler warning signs above as a reason to stop and seek care immediately, not something to push through.

Frequently asked questions